About me

Leon Hess Professor in Internal Medicine

Spoken languages

English

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Dr. Doshi is a Penn Medicine physician.

Qualifications and experience

Treatments and conditions

Research

Publications

Doshi JA, Klebanoff MJ, Merchant M, Li P, Kazi DS “PCSK9 Inhibitor Price Reductions and Medicare Part D Utilization and Spending” , JAMA Cardiology, 11(9): 2026,892-894

Huntington SF, Puckett JT, Manzoor BS, Emechebe N, Li SS, Kamal-Bahl S, Reyes C, Budlong H, Doshi JA "Real-World Overall Survival and Time to Next Treatment Among Medicare Beneficiaries with Chronic Lymphocytic Leukemia in the Frontline Setting" , Cancers, 18(12): 2026,1902

Lin JK, Xiang JJ, Lei X, Desai S, Trish E, Chino F, Li M, Giordano SH, Xu Y, Jiang C, Doshi JA, Shih YCT “Identifying Meaningful Patient Savings on Generics: Direct-to-Consumer Prices Versus Commercial Insurance Cost Sharing” , Annals of Internal Medicine, 179(8): 2026,1210-1212

Li P, Klebanoff MJ, Lin JK, Doshi KD, Chahin S, Doshi JA “Medicare Part D Formulary Coverage of Disease-Modifying Therapies for Multiple Sclerosis” , JAMA Health Forum, 7(4): 2026,e260871

Lin JK, Li P, Lei X, Desai SM, Doshi JA "Specialty Oral Anticancer Prescription Fill Rates After Medicare Part D Cost-Sharing Changes in 2024" , JAMA, 335(4): 2026,366-367

Kaparis S, Eshaghi K, Paruzzo L, Doshi J, Ruella M, Guerra C "CAR-T for All? Barriers, Facilitators, and Interventions to Commercial CAR T-Cell Therapy Access" , Blood Reviews, 76: 2026,101358

Klebanoff MJ, Chetty AK, Doshi JA "Medicaid Coverage and Prior Authorization for Antiobesity Glucagon-Like Peptide-1 Receptor Agonists: A Cross-Sectional Study of State Policies" , J Gen Intern Med, 41(7): 2026,2003-2006

Li P, Lin JK, Klebanoff MJ, Palkar R, Chahin S, Doshi JA "Reducing the Out-of-Pocket Costs of Disease-Modifying Therapies for Medicare Beneficiaries With Multiple Sclerosis" , Neurology Clinical Practice, 15(6): 2025

Lin JK, Niu J, Giordano SH, Li P, Snyder RA, Liao K, Li M, Aparicio A, Chapin W, Zhang J, Xiang J, Perera N, Pain D, Guerra CE, Doshi JA "Racial and ethnic disparities along the treatment cascade among Medicare fee-for-service beneficiaries with metastatic breast, colorectal, lung, and prostate cancers" , Journal of Clinical Oncology, 43(30): 2025,3254-3265

Huntington SF, Rhodes JM, Manzoor BS, Jawaid D, Puckett JT, Emechebe N, Ravelo A, Kamal-Bahl S, Marx SE, Doshi JA "Real-World Treatment Patterns After Discontinuation of Venetoclax or BTKis in the Frontline Setting Among Older Adults With Chronic Lymphocytic Leukemia" , JCO Oncology Practice, 21(8): 2025,1124-1133

Jalpa A. Doshi, PhD